Mark Howard Snyder serves as Executive at HALOZYME THERAPEUTICS, INC., where they oversee executive responsibilities. Since joining the company, Mark Howard Snyder has executed 12 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Feb 23, 2026 involved exercising options for 7,011 shares valued at $0.
Mark Howard Snyder currently holds 14,022 shares of HALOZYME THERAPEUTICS, INC. (HALO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mark Howard Snyder has been a net neutral trader of HALO stock. They have purchased $0 and sold $0 worth of shares.
Mark Howard Snyder's most recent insider trade was on Feb 23, 2026, when they sold 7,011 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $70.64 |
| Discretionary |
| Feb 23, 2026 | HALO | $0 | Option Exercise | 7,011 | $N/A | Discretionary |
| Feb 20, 2026 | HALO | $0 | Option Exercise | 5,332 | $N/A | Discretionary |
| Feb 20, 2026 | HALO | $204.1K | Payment | 2,876 | $70.98 | Discretionary |
| Feb 20, 2026 | HALO | $0 | Option Exercise | 5,332 | $N/A | Discretionary |
| Feb 16, 2024 | HALO | $93.0K | Payment | 2,577 | $36.10 | Discretionary |
| Feb 16, 2024 | HALO | $0 | Option Exercise | 4,796 | $N/A | Discretionary |
| Jan 3, 2024 | HALO | $105.8K | Payment | 2,957 | $35.78 | Discretionary |
| Jan 3, 2024 | HALO | $0 | Option Exercise | 7,611 | $N/A | Discretionary |
| Jan 3, 2023 | HALO | $154.6K | Payment | 2,804 | $55.13 | Discretionary |
| Jan 3, 2023 | HALO | $0 | Option Exercise | 7,611 | $N/A | Discretionary |